Editorial commentary: Brugada syndrome or not? That is the question

Despite its description by the Brugada brothers more than 25 years ago [1], the Brugada syndrome (BrS) remains debated in terms of its genetics, arrhythmogenic mechanisms and clinical management. This is partly because the relationships between genotype, electrocardiographic phenotype, pathoelectrophysiology, and clinical management of BrS continue to evolve, driven by findings in the clinic and in the basic laboratory. The review article by Cerrone [2] offers a timely overview of the clinical and genetic intricacies of BrS, and shines light on the controversies and major scientific and clinical milestones that have been reached since the description of BrS, with a focus on the latest discoveries in the field.
Source: Trends in Cardiovascular Medicine - Category: Cardiology Authors: Source Type: research